Medipal Holdings appoints Choufuku as acting president amid Watanabe's treatment

Medipal Holdings Corporation (TSE: 7459) announced today the appointment of Yasuhiro Choufuku, currently a Director and Vice President, as an additional Representative Director and Acting President, effective May 23, 2025. This decision comes as current Representative Director, President, and CEO Shuichi Watanabe undergoes medical treatment. Choufuku, who will also maintain his role as Vice President, will act on behalf of the president during this period, creating a two-member representative director structure.